Omid Holdings (Omid Holdings) Capex-to-Operating-Income : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Omid Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Omid Holdings's Capital Expenditure for the three months ended in . 20 was $0.00 Mil. Its Operating Income for the three months ended in . 20 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Omid Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Omid Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Capex-to-Operating-Income Chart

Omid Holdings Annual Data

Trend

Capex-to-Operating-Income

Omid Holdings Quarterly Data

Capex-to-Operating-Income

Competitive Comparison of Omid Holdings's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omid Holdings's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Omid Holdings's Capex-to-Operating-Income falls into.

Omid Holdings Capex-to-Operating-Income Calculation

Omid Holdings's Capex-to-Operating-Income for the fiscal year that ended in . 20 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- ()	/
	=	N/A

Omid Holdings's Capex-to-Operating-Income for the quarter that ended in . 20 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- ()	/
	=	N/A

Omid Holdings (OTCPK:OMID) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Omid Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Omid Holdings (Omid Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Capex-to-Operating-Income

Traded in Other Exchanges

N/A

Address

1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865

Website

https://www.omidholdingsinc.com

Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.